For laboratory and research use only. Not for human consumption.
Azure Synthetics Azure Synthetics Research peptides, clearly documented.
PT-141

مواد داعمة لأبحاث الببتيدات

PT-141

مواد داعمة لأبحاث الببتيدات | 10mg

40.99 $
Selected configuration Choose amount and pack size
PT-141 certificate of analysis preview View current COALinked product documentation
Assay listed 98.7%-99.3% See linked documentation

Free standard shipping to eligible destinations · estimated 7–11 business days after dispatch

Checkout options MOSSVisaMastercardAmerican ExpressApple PayGoogle Pay
Laboratory research use only

Not a drug, food, dietary supplement, cosmetic, or medical product. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, mitigate, or prevent disease. These materials have not been evaluated by the U.S. Food and Drug Administration.

Lot documentation COA available to inspect
Available

Batch-linked certificate support is available through the documentation desk.

Open current COA
98.7%-99.3% Lyophilized powder 10 mg

Product record

Specifications and documentation

Product identity
PT-141
CAS number
Available in product documentation
Molecular weight
Available in product documentation
Purity / assay
98.7%-99.3%
الصيغة
Lyophilized powder
Configuration
10 mg
التخزين
Keep sealed, cold, dry, and protected from heat swings. Confirm product-specific storage on arrival.
شهادة التحليل
Direct COA available below

Molecular class

Cyclic melanocortin heptapeptide

Sequence / composition

A cyclic seven-residue peptide from the Melanotan II lineage, with non-native residue substitutions.

Research design note

The cyclic design supports central melanocortin receptor pharmacology studies and should not be treated as a vascular peptide.

External reading

Literature for context

Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.

Keep comparing

Compare other catalog records.

Explore related research materials. These are not a combined-use recommendation.